Compare Cigna Corp (CI) vs Invesco Ltd. (IVZ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cigna Corp vs Invesco Ltd. — how do they compare? Cigna Corp trades at $272.72 (market cap $73.56B), while Invesco Ltd. trades at $31.16 (market cap $14.01B). The key difference: Cigna Corp is far larger — about 5.3× Invesco Ltd.'s market cap, and Invesco Ltd. pays the higher dividend (2.71%). Which is the better fit depends on your goals.
| CI | IVZ | |
|---|---|---|
Market Cap | $73.56B | $14.01B |
Sector | Health | Financials |
52-Week High | $311.00 | $32.01 |
52-Week Low | $244.41 | $20.67 |
Enterprise Value | $98.27B | $24.18B |
Dividend Yield | 2.24% | 2.71% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cigna (CI) trades at $282.49, up 2.63% with strong earnings beats in recent quarters. The stock shows bearish technical signals but benefits from low valuation ratios like a P/E of 11.68 and P/S of 0.27. Recent Q2 2026 results exceeded expectations, with EPS of $7.78 beating estimates, and the company raised its full-year guidance to at least $30.45 adjusted EPS, reflecting robust growth in health services and insurance segments.
The outlook is positive due to consistent earnings outperformance and raised guidance, though technical weakness and competitive pressures pose risks. Analyst consensus is strongly bullish with a $338.90 price target, indicating ~20% upside potential from current levels, supported by dividend payments and institutional accumulation.
Invesco (IVZ) trades at $31.58, near its 52-week high, with a bullish technical signal from moving averages and recent record inflows driving AUM growth. The company reported mixed quarterly EPS results but shows improving cash flow trends, with 2025 operating cash flow at $1.53 billion. Analyst consensus is divided, with 42.9% buy ratings and a $32.50 price target, while negative net income margins and ROE highlight profitability challenges.
The outlook is cautiously optimistic due to strong institutional interest and dividend consistency, but risks include expense pressures and volatile earnings. Investors should weigh the bullish technicals and asset growth against fundamental weaknesses in profitability and margin compression.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cigna Corp
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM services were greatly expanded by its 2018 merger with Express Scripts and are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage. The company operates mostly in the U.S. with 15 million medical members covered as of the end of 2020, but its services extend internationally, covering another 2 million people.
Read more on CI →About Invesco Ltd.
Invesco provides investment-management services to retail (65% of managed assets) and institutional (35%) clients. At the end of August 2022, the firm had $1.416 trillion in assets under management spread among its equity (47% of AUM), balanced (5%), fixed-income (22%), alternative investment (14%), and money market (12%) operations. Passive products account for 32% of Invesco's total AUM, including 56% of the company's equity operations and 13% of its fixed-income platform. Invesco's U.S. retail business is one of the 10 largest nonproprietary fund complexes in the country. The firm also has a meaningful presence outside the U.S., with close to one third of its AUM sourced from Canada (2%), the U.K. (4%), continental Europe (11%), and Asia (15%).
Read more on IVZ →
